Published in:
01-10-2017 | Letter to the Editor
Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients
Authors:
Hershel Raff, David J Kramer, Cecilia J. Hillard
Published in:
Endocrine
|
Issue 1/2017
Login to get access
Excerpt
The endocannabinoid signaling system consists of two G-protein-coupled receptors (CBRs), named CB1 and CB2, and two well-characterized ligands, the endocannabinoids (eCBs) 2-arachidonoylglycerol (2-AG) and
N-arachidonoylethanolamine (AEA) [
1]. Although the roles of these molecules in the circulation are not well understood, their concentrations change under the conditions of physiological and psychological stress [
1]. In particular, 2-AG and AEA concentrations have been reported to be increased in patients with endotoxic shock, infection, and following cardiac surgery [
1]. To further our understanding of the roles of endocannabinoids in human disease states associated with severe physiological stress, we compared circulating concentrations of 2-AG and AEA in blood obtained from septic patients within 24 h of admission to the ICU to the same measures in healthy controls. …